V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007916 | 240010707 | 1.6 | 68 | Curative (C) | 2014-06-17 | 2014-06-21 | METHOTREXATE | N | N | 240035062 | mEOC TRIAL |
| 240008331 | 240005105 | 1.6 | 63.4 | Curative (C) | 2014-06-16 | 2014-06-17 | MPV (cycle 1-4) | 02 | N | 240008302 | mEOC TRIAL |
| 170012743 | 170004612 | null | 61.05 | Palliative (P) | 2015-04-29 | 2015-04-29 | Trial Unspecified | 99 | N | 170027659 | mEOC TRIAL |
| 170031607 | 170012937 | 1.71 | null | Palliative (P) | 2014-05-01 | 2014-06-12 | Docetaxel 100mg/m2 (21 day) | N | N | 170027257 | mEOC TRIAL |
| 170012906 | 170004679 | null | null | null | 2013-09-16 | 2013-09-17 | OCTOPUS Trial | Y | N | 170028002 | mEOC TRIAL |
| 170012971 | 170004707 | 1.58 | 112 | Palliative (P) | 2014-12-27 | 2014-12-31 | ICON8B TRIAL | 01 | N | 170003016 | mEOC TRIAL |
| 170013200 | 170004789 | 1.6 | 52.8 | Neo-adjuvant (N) | 2017-05-09 | 2017-05-26 | ICON8B TRIAL | Y | N | 170014554 | mEOC TRIAL |
| 170013468 | 170016657 | 1.52 | 81 | Neo-adjuvant (N) | 2018-09-13 | 2018-09-17 | ICON8B TRIAL | 01 | N | 170003638 | mEOC TRIAL |
| 240008199 | 240005025 | 1.73 | 75.3 | Palliative (P) | 2017-09-17 | 2017-09-19 | Etoposide oral | N | N | 240003557 | mEOC TRIAL |
| 170021213 | 170013418 | null | null | Palliative (P) | 2013-03-31 | 2013-12-14 | Chlorambucil | N | null | 170021898 | mEOC TRIAL |
| 170012788 | 170004628 | 1.7 | 69.2 | Curative (C) | 2013-07-13 | 2013-07-23 | ICON8B TRIAL | 01 | N | 170027768 | mEOC TRIAL |
| 170026011 | 170021182 | 1.6 | 76.4 | Palliative (P) | 2016-05-08 | 2016-05-14 | mEOC TRIAL | N | N | 170011868 | mEOC TRIAL |
| 170026043 | 170013342 | 1.78 | 101.7 | Adjuvant (A) | 2017-06-28 | 2017-09-07 | Trastuzumab Subcutaneous | N | N | 170015714 | mEOC TRIAL |
| 170026060 | 170013365 | 1.65 | 62.7 | Palliative (P) | 2018-12-10 | 2018-12-11 | EP | 02 | N | 170018246 | mEOC TRIAL |
| 170028822 | 170012937 | 1.69 | 72 | Palliative (P) | null | 2014-06-12 | TCH (21 day Trastuzumab) Maint | 02 | N | 170027257 | mEOC TRIAL |
| 170030558 | 170012932 | 1.6 | 63.5 | Not known (9) | 2016-06-29 | 2016-07-23 | Oxaliplatin + Modified de Gramont | N | N | 170027242 | mEOC TRIAL |
| 170030559 | 170012937 | 1.71 | 98.2 | Palliative (P) | 2014-04-13 | 2014-06-12 | SOLO1 TRIAL | N | N | 170027257 | mEOC TRIAL |
| 170030572 | 170013017 | 1.65 | 85 | Palliative (P) | 2018-08-18 | 2019-06-11 | TCH (21 day Trastuzumab) Maint | 02 | Y | 170027503 | mEOC TRIAL |
| 170025932 | 170013160 | 1.64 | 58.6 | Palliative (P) | 2014-07-02 | 2014-07-06 | null | N | N | 170028004 | mEOC TRIAL |
| 320003946 | 320002415 | 1.68 | 89.4 | Palliative (P) | null | 2014-03-05 | Gemcitabine + Capecitabine | null | null | 320009509 | mEOC TRIAL |
| 240016165 | 240008986 | 1.59 | 95.3 | Disease modification (D) | 2015-12-22 | 2016-01-12 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | N | null | 240033328 | mEOC TRIAL |
| 240016132 | 240008651 | 1.59 | null | Curative (C) | 2017-03-08 | 2017-03-07 | Vinblastine | 2 | N | 240008306 | mEOC TRIAL |
| 240012575 | 240008777 | 0 | 55.9 | Curative (C) | 2017-06-24 | 2017-07-15 | Carboplatin + Liposomal Doxorubicin | null | null | 240016111 | mEOC TRIAL |
| 240012487 | 240008686 | 1.59 | 69 | null | 2014-04-10 | 2014-04-10 | ETOPOSIDE | 02 | N | 240009832 | mEOC TRIAL |
| 240009029 | 240005488 | null | null | null | null | 2018-04-06 | GEMCARBO | N | N | 240028406 | mEOC TRIAL |
| 240008136 | 240004995 | 1.5 | 64.9 | Disease modification (D) | 2018-05-13 | 2018-05-28 | Cytarabine intrathecal | N | N | 240001854 | mEOC TRIAL |
| 240008666 | 240013639 | 1.54 | null | null | null | 2013-02-01 | FLAG | Y | null | 240019851 | mEOC TRIAL |
| 240008438 | 240005160 | 1.53 | 67.7 | null | 2016-11-12 | 2016-11-12 | CISPLATIN + ETOPOSIDE | 2 | N | 240011155 | mEOC TRIAL |
| 240008349 | 240005113 | null | 36.55 | Curative (C) | 2013-11-01 | 2013-11-03 | ETOPOSIDE | N | null | 240008851 | mEOC TRIAL |
| 170021202 | 170013402 | 1.68 | 115.4 | Palliative (P) | 2016-06-19 | 2017-01-27 | Oxaliplatin + Modified de Gramont | 02 | N | 170020289 | mEOC TRIAL |
| 90008324 | 90005634 | 1.9 | 103 | Adjuvant (A) | 2015-03-10 | 2015-03-10 | Ipilimumab | 1 | N | 90007519 | ZEBRA TRIAL |
| 90008151 | 90005470 | 1.77 | 97.4 | Palliative (P) | 2018-06-19 | 2018-06-20 | EVEROLIMUS | N | N | 90039548 | ZEBRA TRIAL |
| 200024650 | 200015765 | null | 85.6 | Disease modification (D) | null | 2014-09-21 | CHOP - 21 days | N | N | 200045225 | Z-DEX |
| 200030281 | 200030402 | 1.76 | 69 | Palliative (P) | 2018-06-25 | 2018-07-05 | CHOP - 21 days | N | N | 200044295 | Z-DEX |
| 200035421 | 200015491 | null | 58.2 | Disease modification (D) | 2018-03-31 | 2018-05-26 | PANOBINOSTAT | N | N | 200042510 | Z-DEX |
| 200035293 | 200014543 | 1.72 | 49.2 | Palliative (P) | 2016-11-03 | 2016-11-04 | Capecitabine | 2 | N | 200031092 | Z-DEX |
| 200033385 | 200014953 | 1.59 | 84.4 | Disease modification (D) | 2014-02-02 | 2014-02-02 | OXALIPLATIN | N | N | 200036143 | Z-DEX |
| 200030412 | 200030470 | 1.78 | 90.4 | Palliative (P) | 2016-08-08 | 2016-08-08 | CHOP - 21 days | 2 | N | 200013178 | Z-DEX |
| 200030402 | 200015898 | 1.7 | 0 | Disease modification (D) | 2018-11-07 | 2018-11-07 | DARATUMUMAB | N | N | 200009057 | Z-DEX |
| 200036536 | 200030372 | 1.8 | 79.5 | Curative (C) | 2019-11-10 | 2019-11-27 | GemCarbo Days 1+8 | N | N | 200043211 | Z-DEX |
| 200030257 | 200024756 | 1.71 | 80.5 | Palliative (P) | 2016-01-16 | 2016-01-17 | PAD | 01 | N | 200043828 | Z-DEX |
| 200024649 | 200015765 | 1.72 | 74.95 | Adjuvant (A) | null | 2015-12-03 | MYELOMA XII TRIAL | null | N | 200045225 | Z-DEX |
| 200015785 | 200006662 | 1.69 | 73.1 | Curative (C) | 2015-07-22 | 2015-07-27 | Cisplatin | null | N | 200017053 | Z-DEX |
| 200015450 | 200006543 | 1.71 | 89.4 | Disease modification (D) | 2013-06-28 | 2013-07-17 | POMALIDOMIDE | 02 | N | 200045326 | Z-DEX |
| 200015394 | 200006526 | 1.69 | 43.1 | Palliative (P) | 2014-03-19 | 2014-03-20 | PAD | N | N | 200044993 | Z-DEX |
| 200015300 | 200006494 | 1.74 | 80 | Palliative (P) | 2015-10-26 | 2015-11-26 | Rituximab | 2 | Y | 200044429 | Z-DEX |
| 200015274 | 200006485 | null | 99.3 | Palliative (P) | 2013-03-15 | 2013-03-20 | BORTEZOMIB + DOXORUBICIN | N | N | 200044282 | Z-DEX |
| 230000681 | 230000396 | 1.7 | 96.5 | Palliative (P) | 2018-10-06 | 2018-10-17 | CAPECITABINE + OXALIPLATIN | N | N | 230009388 | Y-90 |
| 270018459 | 270010404 | 1.72 | 87 | Curative (C) | 2018-01-30 | 2018-02-11 | NHL 2003 Gp B COP | 02 | N | 270021016 | Y-90 |
| 290004484 | 290003291 | 1.59 | 62.5 | Disease modification (D) | 2014-07-07 | 2014-07-07 | PACLITAXEL | N | N | 290021270 | Y-90 |